Novus Acquisition & Development Corp.
NDEV News Today: Stay Updated with the Latest Novus Acquisition & Development Corp. News in Real Time
Find NDEV news now at Meyka AI. Stay informed with the latest Novus Acquisition & Development Corp. stocks updates, including price news, market analysis, and expert insights.
Unisound AI Technology (9678.HK) Drops 4.4% as AGI Ambitions Face Valuation Pressure
9678.HK stock falls 4.4% to HK$286.6 amid broader AI sector volatility. Unisound AI trades below 50-day average as market reassesses LLM valuations.
FBI Offers $200K Reward for Monica Witt May 15: Espionage Case Heats Up
FBI offers $200,000 reward for Monica Witt, former Air Force intelligence specialist charged with espionage for Iran since 2013.
Kiwetinohk Energy Corp. (KEC.TO) Holds Steady at C$24.73 Amid Energy Transition
KEC.TO stock trades near year highs at C$24.73 with strong 46.8% one-year gain. Energy transition play in oil & gas exploration.
Tempest Minerals Limited (TEM.AX) Holds at A$0.006 Amid Exploration Focus
TEM.AX stock trades flat at A$0.006 on ASX. Tempest Minerals explores lithium and gold deposits in Western Australia.
NIU Holdings Limited Stock Tumbles 20.7% on Weak Trading Momentum
8619.HK stock drops 20.7% to HK$0.195 amid weak trading momentum. Engineering firm faces headwinds in Hong Kong construction sector.
Boustead Singapore Limited (F9D.SI) Drops 4.7% Ahead of May 21 Earnings
F9D.SI stock falls 4.7% to S$2.42 as investors await May 21 earnings announcement. Meyka AI rates the conglomerate with a B+ grade.
Monitor Ventures Inc. (AVCVF) Crashes 99.98% as Company Winds Down Operations
AVCVF stock plummets 99.98% to near-zero levels as Monitor Ventures winds down with no active operations remaining.
Kaarya Facilities Stock Drops 5% in Pre-Market; Oversold Bounce Signals Recovery
KAARYAFSL.BO stock falls 5% but trades above 200-day average. Oversold conditions suggest potential bounce for facilities management firm.
Medigene AG Stock Tumbles 22% as Biotech Liquidation Deepens
MDG1.F stock crashes 22% in pre-market trading as Medigene AG continues asset liquidation. Munich biotech faces steep decline.